Daré Bioscience Announces Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic
Daré Bioscience (NASDAQ: DARE) announced the upcoming June 2026 launch of its first consumer health product, Flora Sync LF5™, a vaginal probiotic capsule. The CEO highlighted this as an opportunity to generate direct revenue and expand Daré's leadership in women’s health.
Tickers: $DARE
Topics: biotech innovation consumer product launch women's health